Altered Gene Expression along the Glycolysis-Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic Cancer

被引:153
作者
Karasinska, Joanna M. [1 ]
Topham, James T. [1 ]
Kalloger, Steve E. [1 ,2 ]
Jang, Gun Ho [3 ]
Denroche, Robert E. [3 ]
Culibrk, Luka [4 ]
Williamson, Laura M. [4 ]
Wong, Hui-Li [5 ]
Lee, Michael K. C. [5 ]
O'Kane, Grainne M. [6 ]
Moore, Richard A. [4 ]
Mungall, Andrew J. [4 ]
Moore, Malcolm J. [5 ]
Warren, Cassia [1 ]
Metcalfe, Andrew [1 ]
Notta, Faiyaz [3 ]
Knox, Jennifer J. [6 ]
Gallinger, Steven [3 ,6 ]
Laskin, Janessa [4 ,5 ]
Marra, Marco A. [4 ,7 ]
Jones, Steven J. M. [4 ,7 ]
Renouf, Daniel J. [1 ,5 ,8 ]
Schaeffer, David F. [1 ,2 ,9 ]
机构
[1] Pancreas Ctr BC, Vancouver, BC, Canada
[2] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada
[3] Ontario Inst Canc Res, Toronto, ON, Canada
[4] Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada
[5] BC Canc, Div Med Oncol, Vancouver, BC, Canada
[6] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada
[7] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada
[8] Univ British Columbia, Dept Med, Vancouver, BC, Canada
[9] Vancouver Gen Hosp, Div Anat Pathol, Vancouver, BC, Canada
基金
加拿大创新基金会;
关键词
MITOCHONDRIAL PYRUVATE CARRIER; STATIN USE; MUTATIONAL LANDSCAPE; METABOLISM; SUBTYPES; TUMOR; PATHWAY; GROWTH; DEFINES; RISK;
D O I
10.1158/1078-0432.CCR-19-1543
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Identification of clinically actionable molecular subtypes of pancreatic ductal adenocarcinoma (PDAC) is key to improving patient outcome. Intertumoral metabolic heterogeneity contributes to cancer survival and the balance between distinct metabolic pathways may influence PDAC outcome. We hypothesized that PDAC can be stratified into prognostic metabolic subgroups based on alterations in the expression of genes involved in glycolysis and cholesterol synthesis. Experimental Design: We performed bioinformatics analysis of genomic, transcriptomic, and clinical data in an integrated cohort of 325 resectable and nonresectable PDAC. The resectable datasets included retrospective The Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium (ICGC) cohorts. The nonresectable PDAC cohort studies included prospective COMPASS, PanGen, and BC Cancer Personalized OncoGenomics program (POG). Results: On the basis of the median normalized expression of glycolytic and cholesterogenic genes, four subgroups were identified: quiescent, glycolytic, cholesterogenic, and mixed. Glycolytic tumors were associated with the shortest median survival in resectable (log-rank test P = 0.018) and metastatic settings (log-rank test P = 0.027). Patients with cholesterogenic tumors had the longest median survival. KRAS and MYC-amplified tumors had higher expression of glycolytic genes than tumors with normal or lost copies of the oncogenes (Wilcoxon rank sum test P = 0.015). Glycolytic tumors had the lowest expression of mitochondrial pyruvate carriers MPC1 and MPC2. Glycolytic and cholesterogenic gene expression correlated with the expression of prognostic PDAC subtype classifier genes. Conclusions: Metabolic classification specific to glycolytic and cholesterogenic pathways provides novel biological insight into previously established PDAC subtypes and may help develop personalized therapies targeting unique tumor metabolic profiles.
引用
收藏
页码:135 / 146
页数:12
相关论文
共 49 条
[1]   Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine [J].
Aguirre, Andrew J. ;
Nowak, Jonathan A. ;
Camarda, Nicholas D. ;
Moffitt, Richard A. ;
Ghazani, Arezou A. ;
Hazar-Rethinam, Mehlika ;
Raghavan, Srivatsan ;
Kim, Jaegil ;
Brais, Lauren K. ;
Ragon, Dorisanne ;
Welch, Marisa W. ;
Reilly, Emma ;
McCabe, Devin ;
Marini, Lori ;
Anderka, Kristin ;
Helvie, Karla ;
Oliver, Nelly ;
Babic, Ana ;
Da Silva, Annacarolina ;
Nadres, Brandon ;
Van Seventer, Emily E. ;
Shahzade, Heather A. ;
St Pierre, Joseph P. ;
Burke, Kelly P. ;
Clancy, Thomas ;
Cleary, James M. ;
Doyle, Leona A. ;
Jajoo, Kunal ;
McCleary, Nadine J. ;
Meyerhardt, Jeffrey A. ;
Murphy, Janet E. ;
Ng, Kimmie ;
Patel, Anuj K. ;
Perez, Kimberly ;
Rosenthal, Michael H. ;
Rubinson, Douglas A. ;
Ryou, Marvin ;
Shapiro, Geoffrey I. ;
Sicinska, Ewa ;
Silverman, Stuart G. ;
Nagy, Rebecca J. ;
Lanman, Richard B. ;
Knoerzer, Deborah ;
Welsch, Dean J. ;
Yurgelun, Matthew B. ;
Fuchs, Charles S. ;
Garraway, Levi A. ;
Getz, Gad ;
Hornick, Jason L. ;
Johnson, Bruce E. .
CANCER DISCOVERY, 2018, 8 (09) :1096-1111
[2]   Systematic pan-cancer analysis of tumour purity [J].
Aran, Dvir ;
Sirota, Marina ;
Butte, Atul J. .
NATURE COMMUNICATIONS, 2015, 6
[3]   Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial [J].
Aung, Kyaw L. ;
Fischer, Sandra E. ;
Denroche, Robert E. ;
Jang, Gun-Ho ;
Dodd, Anna ;
Creighton, Sean ;
Southwood, Bernadette ;
Liang, Sheng-Ben ;
Chadwick, Dianne ;
Zhang, Amy ;
O'Kane, Grainne M. ;
Albaba, Hamzeh ;
Moura, Shari ;
Grant, Robert C. ;
Miller, Jessica K. ;
Mbabaali, Faridah ;
Pasternack, Danielle ;
Lungu, Ilinca M. ;
Bartlett, John M. S. ;
Ghai, Sangeet ;
Lemire, Mathieu ;
Holter, Spring ;
Connor, Ashton A. ;
Moffitt, Richard A. ;
Yeh, Jen Jen ;
Timms, Lee ;
Krzyzanowski, Paul M. ;
Dhani, Neesha ;
Hedley, David ;
Notta, Faiyaz ;
Wilson, Julie M. ;
Moore, Malcolm J. ;
Gallinger, Steven ;
Knox, Jennifer J. .
CLINICAL CANCER RESEARCH, 2018, 24 (06) :1344-1354
[4]   MCT4 Defines a Glycolytic Subtype of Pancreatic Cancer with Poor Prognosis and Unique Metabolic Dependencies [J].
Baek, GuemHee ;
Tse, Yan F. ;
Hu, Zeping ;
Cox, Derek ;
Buboltz, Noah ;
McCue, Peter ;
Yeo, Charles J. ;
White, Michael A. ;
DeBerardinis, Ralph J. ;
Knudsen, Erik S. ;
Witkiewicz, Agnieszka K. .
CELL REPORTS, 2014, 9 (06) :2233-2249
[5]   DEVIANT ENERGETIC METABOLISM OF GLYCOLYTIC CANCER-CELLS [J].
BAGGETTO, LG .
BIOCHIMIE, 1992, 74 (11) :959-974
[6]   Genomic analyses identify molecular subtypes of pancreatic cancer [J].
Bailey, Peter ;
Chang, David K. ;
Nones, Katia ;
Johns, Amber L. ;
Patch, Ann-Marie ;
Gingras, Marie-Claude ;
Miller, David K. ;
Christ, Angelika N. ;
Bruxner, Tim J. C. ;
Quinn, Michael C. ;
Nourse, Craig ;
Murtaugh, L. Charles ;
Harliwong, Ivon ;
Idrisoglu, Senel ;
Manning, Suzanne ;
Nourbakhsh, Ehsan ;
Wani, Shivangi ;
Fink, Lynn ;
Holmes, Oliver ;
Chin, Vencssa ;
Anderson, Matthew J. ;
Kazakoff, Stephen ;
Leonard, Conrad ;
Newell, Felicity ;
Waddell, Nick ;
Wood, Scott ;
Xu, Qinying ;
Wilson, Peter J. ;
Cloonan, Nicole ;
Kassahn, Karin S. ;
Taylor, Darrin ;
Quek, Kelly ;
Robertson, Alan ;
Pantano, Lorena ;
Mincarelli, Laura ;
Sanchez, Luis N. ;
Evers, Lisa ;
Wu, Jianmin ;
Pinese, Mark ;
Cowley, Mark J. ;
Jones, Marc D. ;
Colvin, Emily K. ;
Nagrial, Adnan M. ;
Humphrey, Emily S. ;
Chantrill, Lorraine A. ;
Mawson, Amanda ;
Humphris, Jeremy ;
Chou, Angela ;
Pajic, Marina ;
Scarlett, Christopher J. .
NATURE, 2016, 531 (7592) :47-+
[7]   TIGAR, a p53-inducible regulator of glycolysis and apoptosis [J].
Bensaad, Karim ;
Tsuruta, Atsushi ;
Selak, Mary A. ;
Calvo Vidal, M. Nieves ;
Nakano, Katsunori ;
Bartrons, Ramon ;
Gottlieb, Eyal ;
Vousden, Karen H. .
CELL, 2006, 126 (01) :107-120
[8]   Uncoupling Nuclear Receptor LXR and Cholesterol Metabolism in Cancer [J].
Bovenga, Fabiola ;
Sabba, Carlo ;
Moschetta, Antonio .
CELL METABOLISM, 2015, 21 (04) :517-526
[9]   A Mitochondrial Pyruvate Carrier Required for Pyruvate Uptake in Yeast, Drosophila, and Humans [J].
Bricker, Daniel K. ;
Taylor, Eric B. ;
Schell, John C. ;
Orsak, Thomas ;
Boutron, Audrey ;
Chen, Yu-Chan ;
Cox, James E. ;
Cardon, Caleb M. ;
Van Vranken, Jonathan G. ;
Dephoure, Noah ;
Redin, Claire ;
Boudina, Sihem ;
Gygi, Steven P. ;
Brivet, Michele ;
Thummel, Carl S. ;
Rutter, Jared .
SCIENCE, 2012, 337 (6090) :96-100
[10]   JAGuaR: Junction Alignments to Genome for RNA-Seq Reads [J].
Butterfield, Yaron S. ;
Kreitzman, Maayan ;
Thiessen, Nina ;
Corbett, Richard D. ;
Li, Yisu ;
Pang, Johnson ;
Ma, Yussanne P. ;
Jones, Steven J. M. ;
Birol, Inanc .
PLOS ONE, 2014, 9 (07)